The sphingolipid inhibitor myriocin increases susceptibility of Candida auris to amphotericin B
H. Stieber, L. Junghanns, H. Wilhelm, M. Batliner, A. M. Aldejohann, O. Kurzai, R. Martin
This study shows that myriocin, a sphingolipid inhibitor, increases susceptibility of Candida auris to amphotericin B and anidulafungin, suggesting sphingolipids as a target for overcoming resistance.
bioRxiv · Apr 14, 2022Microbiology